Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Ophthalmology. 2017 Feb 23;124(6):873–883. doi: 10.1016/j.ophtha.2017.01.029

Table 1.

Characteristics of Study Participants.

Subject ID Age (Yrs) at Re-administration and Baseline fMRI Re-administered Eye RPE65 mutation(s)
NP02 30 Left E102K/E102K
CH08 12 Left F530fs/F530fs
CH09 11 Right R124X/K297del1aggA
CH10 14 Left IVS1+5g>a/F530del1ttc
CH11 26 Left V473D/V473D
CH12 46 Left K303X/W431C
NP15 14 Left D167W/H313R